tirzepatide weight loss clinical trial New trial: Zepbound (tirzepatide) helped adults lose an average of 20.2% of their body weight—around 50 lbs—over 72 weeks, outperforming Wegovy's 13.7% (~33 lbs). Credit to: https://www.healthline.com/health-news/zepbound-wegovy-weight-loss New drug tirzepatide delivers significant
Description
Symptomatic relief: Over-the-counter antihistamines (such as cetirizine or loratadine) may help relieve itching and reduce hives
New Drug Forms Some online compounding pharmacies have begun selling oral forms of semaglutide and tirzepatide, which are typically administered with an injection
Recording injection dates, doses, any side effects, and progress metrics creates valuable data for refining approaches
Expect a dose adjustment period
Patients should consult their GP or pharmacist before starting any new medication to ensure there are no contraindications or drug interactions with their current medicines
